Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-09

Clinical Trial Update: Sildenafil in Hemodialysis Patients With Pulmonary Hypertension [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating sildenafil in patients on hemodialysis with pulmonary hypertension; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Ain Shams University | Conditions: Pulmonary Hypertension, Hemodialysis Complication | Phase 2, Phase 3 | Status: UNKNOWN